Highbridge Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$1.25M | – | 208 |
|
|
2019
Q1 | $1.25M | Sell |
10,000
-3,750
| -27% | -$470K | 0.04% | 185 |
|
|
2018
Q4 | $1.55M | Buy |
13,750
+3,750
| +38% | +$423K | 0.05% | 175 |
|
|
2018
Q3 | $2.14M | Buy |
+10,000
| New | +$2.14M | 0.05% | 265 |
|
|
2015
Q3 | – | Sell |
-999
| Closed | -$78K | – | 1040 |
|
|
2015
Q2 | $78K | Sell |
999
-3,209
| -76% | -$251K | ﹤0.01% | 779 |
|
|
2015
Q1 | $286K | Sell |
4,208
-7,133
| -63% | -$485K | ﹤0.01% | 677 |
|
|
2014
Q4 | $1.05M | Sell |
11,341
-746
| -6% | -$69.2K | 0.01% | 455 |
|
|
2014
Q3 | $1.27M | Buy |
12,087
+11,521
| +2,036% | +$1.21M | 0.02% | 469 |
|
|
2014
Q2 | $81K | Buy |
+566
| New | +$81K | ﹤0.01% | 692 |
|
|
2013
Q3 | – | Sell |
-926
| Closed | -$162K | – | 1040 |
|
|
2013
Q2 | $162K | Buy |
+926
| New | +$162K | ﹤0.01% | 852 |
|